Loading clinical trials...
Loading clinical trials...
Economic Impact of Reducing Hospital Admissions for Patients Presenting to the Emergency Department With Worsening Heart Failure: An Adaptive Clinical Trial of Furoscix Infusor
Conditions
Interventions
Furoscix Infusor
Locations
8
United States
Olive View - UCLA Medical Center
Sylmar, California, United States
Bridgeport Hospital
Bridgeport, Connecticut, United States
Tampa General Hospital
Tampa, Florida, United States
Ascension St. Vincent Heart Center
Indianapolis, Indiana, United States
Unity Point Health
Des Moines, Iowa, United States
University of Minnesota Medical Center
Minneapolis, Minnesota, United States
Start Date
November 12, 2020
Primary Completion Date
June 24, 2021
Completion Date
June 24, 2021
Last Updated
February 24, 2023
NCT07037459
NCT06874556
NCT07113223
NCT07191730
NCT06307652
NCT07484009
Lead Sponsor
scPharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions